RGPD4-AS1

Across TCGA pan-cancer cohorts, RGPD4-AS1 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RGPD4-AS1 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher RGPD4-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RGPD4-AS1 expression acts as an unfavorable survival marker, although some lineages such as LUAD and CESC show a favorable association.

MESO, CHOL, and KICH are the cancer types where RGPD4-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Tertile	II,III,IV	0.141	0.394	.001	90	view →
CHOL	OS	Tertile	All	0.024	0.675	<.001	54	view →
KICH	OS	Tertile	All	0.082	0.877	<.001	54	view →
LUAD	DFS	Tertile	II,III,IV	0.807	0.201	.008	51	view →
BRCA	DFS	Tertile	II,III,IV	0.785	0.900	<.001	48	view →
CESC	DFS	Tertile	III,IV	0.884	0.305	.013	48	view →
ACC	DFS	Tertile	All	0.105	0.633	.010	42	view →
THCA	DFS	Tertile	II,III,IV	0.317	0.718	.001	36	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	27	view →
BLCA	OS	Tertile	IV	0.686	0.427	.031	9	view →
LUSC	DFS	Tertile	All	0.734	0.624	.045	6	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RGPD4-AS1–MESO (DFS)

Open the MESO breakdown →